Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Feist

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Zeitschrift Fur Rheumatologie|June 20, 2014
[Rituximab: Half dose with full strength?]E Feist
Zeitschrift Fur Rheumatologie|December 17, 2009
[Critical overview of outcome parameters for patients with primary Sjögren's syndrome]E Feist, A Hansen
Zeitschrift Fur Rheumatologie|August 10, 2010
[Rituximab]E Feist, T Dörner
Zeitschrift Fur Rheumatologie|December 11, 2012
[Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy]E Feist, T Dörner
Zeitschrift Fur Rheumatologie|June 19, 2010
[Diseases of the outer eye in rheumatoid arthritis]E Feist, U Pleyer
Zeitschrift Fur Rheumatologie|February 9, 2013
[Personalized medicine in rheumatology - hype or hope?]G-R Burmester, E Feist
Deutsche Medizinische Wochenschrift (1946)|June 16, 2007
[Rheumatology 2007]E Feist, G R Burmester
Journal of Neurochemistry|May 1, 1989
Most synaptic vesicles isolated from rat brain carry three membrane proteins, SV2, synaptophysin, and p65E Floor, B E Feist
Der Pathologe|October 14, 2006
[Labial salivary gland biopsy in Sjögren's syndrome]A Dankof, L Morawietz, E Feist
Zeitschrift Fur Rheumatologie|November 14, 2007
[Indications and options of new immune modulatory therapies for Sjögren's syndrome]E Feist, T Dörner, A Hansen
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Zeitschrift Fur Rheumatologie|June 20, 2014
[Rituximab: Half dose with full strength?]E Feist
Zeitschrift Fur Rheumatologie|December 17, 2009
[Critical overview of outcome parameters for patients with primary Sjögren's syndrome]E Feist, A Hansen
Zeitschrift Fur Rheumatologie|August 10, 2010
[Rituximab]E Feist, T Dörner
Zeitschrift Fur Rheumatologie|December 11, 2012
[Personalized medicine for rheumatoid arthritis : serological and clinical patient profiles to optimize B and T cell targeted therapy]E Feist, T Dörner
Zeitschrift Fur Rheumatologie|June 19, 2010
[Diseases of the outer eye in rheumatoid arthritis]E Feist, U Pleyer
Zeitschrift Fur Rheumatologie|February 9, 2013
[Personalized medicine in rheumatology - hype or hope?]G-R Burmester, E Feist
Deutsche Medizinische Wochenschrift (1946)|June 16, 2007
[Rheumatology 2007]E Feist, G R Burmester
Journal of Neurochemistry|May 1, 1989
Most synaptic vesicles isolated from rat brain carry three membrane proteins, SV2, synaptophysin, and p65E Floor, B E Feist
Der Pathologe|October 14, 2006
[Labial salivary gland biopsy in Sjögren's syndrome]A Dankof, L Morawietz, E Feist
Zeitschrift Fur Rheumatologie|November 14, 2007
[Indications and options of new immune modulatory therapies for Sjögren's syndrome]E Feist, T Dörner, A Hansen
Pageof 9